In-Silico Evaluation of Genetic Alterations in Ovarian Carcinoma and Therapeutic Efficacy of NSC777201, as a Novel Multi-Target Agent for TTK, NEK2, and CDK1

Ovarian cancer is often detected at the advanced stages at the time of initial diagnosis. Early-stage diagnosis is difficult due to its asymptomatic nature, where less than 30% of 5-year survival has been noticed. The underlying molecular events associated with the disease’s pathogenesis have yet to...

Descripción completa

Detalles Bibliográficos
Autores principales: Khedkar, Harshita Nivrutti, Wang, Yu-Chi, Yadav, Vijesh Kumar, Srivastava, Prateeti, Lawal, Bashir, Mokgautsi, Ntlotlang, Sumitra, Maryam Rachmawati, Wu, Alexander T. H., Huang, Hsu-Shan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8198179/
https://www.ncbi.nlm.nih.gov/pubmed/34072728
http://dx.doi.org/10.3390/ijms22115895

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8198179/
https://www.ncbi.nlm.nih.gov/pubmed/34072728
http://dx.doi.org/10.3390/ijms22115895

Ejemplares similares